Morbilliform Eruptions in the Blood and Marrow Transplant Unit

The presentation focused on morbilliform eruptions experienced by patients in the blood and marrow transplant unit, specifically distinguishing between pre-transplant and post-transplant scenarios. It began with a brief overview of acute leukemia treatment phases: induction, consolidation, and maintenance, highlighting the complexity of patient care and the various medications patients may receive. The speaker detailed different morbilliform eruptions seen in pre-transplant patients, using a fictional case of a 32-year-old patient with AML. The discussion included common conditions such as cytarabine-induced eruptions and eruptions of lymphocyte recovery, emphasizing the need for clinical acumen in diagnosis given the overlapping symptoms and histopathological features. Transitioning to post-transplant eruptions, the talk covered the likelihood of graft versus host disease (GVHD) and engraftment syndrome, highlighting their clinical presentations, histological findings, and timing relative to transplant recovery. GVHD was noted as a significant cause of morbidity and mortality, with key differentiators presented for identifying it compared to other rash-related conditions. The speaker wrapped up with a comprehensive summary differentiating between lymphocyte recovery eruptions, engraftment syndrome, and GVHD based on timing, clinical presentation, and laboratory indicators, clarifying their prevalence among different transplant patient populations.